Wego has provided $34m for Neurovasc in connection with a joint development agreement and clinical trials covering neurovascular disease treatments.

Neurovasc Technologies, a US-based medical device developer focused on neurovascular disease, picked up $34m in funding on Thursday from single-use medical device manufacturer Wego.

Founded in 2015, Neurovasc is working on a portfolio of products aimed at unmet needs in the treatment of neurovascular diseases, including strokes.

The company’s lead product is a mechanical thrombectomy system designed to retrieve clots in difficult-to-reach areas. It is aimed at conditions such as acute ischemic stroke (AIS), where a clot blocks bloodflow to…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.